查找临床试验
已按「特应性皮炎」检索，对应国际通用词 atopic dermatitis
共找到 44 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 23:03，每 5 分钟自动同步A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
United States、China、Germany、Hungary、Japan 等 8 国
年龄 6 Years – 11 Years
Pfizer
A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis
China
年龄 18 Years – 不限
Jiangsu vcare pharmaceutical technology co., LTD
ICP-332 in Subjects With Moderate to Severe Atopic Dermatitis
China
年龄 18 Years – 75 Years
Beijing InnoCare Pharma Tech Co., Ltd.
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
Australia、China、New Zealand
年龄 18 Years – 65 Years
Zai Lab (Shanghai) Co., Ltd.
Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis
China
年龄 18 Years – 75 Years
Shanghai Longwood Biopharmaceuticals Co., Ltd.
A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis
China
年龄 18 Years – 75 Years
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase II Clinical Study to Evaluate the Efficacy and Safety of LT-002-158 Tablets in Adult Patients With Moderate-to-Severe Atopic Dermatitis
China
年龄 18 Years – 75 Years
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
China
年龄 不限 – 不限
Peking University First Hospital
A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic Dermatitis
China
年龄 18 Years – 65 Years
ChinaNorm
A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic Dermatitis
China
年龄 18 Years – 75 Years
Innovent Biologics (Suzhou) Co. Ltd.
Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children
Hong Kong
年龄 4 Years – 17 Years
Chinese University of Hong Kong
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
China
年龄 18 Years – 不限
Keymed Biosciences Co.Ltd